Novem Group Zoetis Inc. Transaction History
Novem Group
- $686 Billion
- Q4 2024
A detailed history of Novem Group transactions in Zoetis Inc. stock. As of the latest transaction made, Novem Group holds 4,899 shares of ZTS stock, worth $767,379. This represents 0.12% of its overall portfolio holdings.
Number of Shares
4,899Holding current value
$767,379% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding ZTS
# of Institutions
2,050Shares Held
419MCall Options Held
1.22MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA41.4MShares$6.48 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.77 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.11 Billion0.13% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.51 Billion2.4% of portfolio
-
Morgan Stanley New York, NY11.8MShares$1.86 Billion0.14% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $73.3B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...